Investors & Media
Corporate Profile
Millendo Therapeutics is a biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases. We create distinct and transformative treatments for endocrine diseases where there is a significant unmet medical need. We are currently advancing MLE-301 for the treatment of vasomotor symptoms (VMS) associated with menopause.
Corporate Presentation
Stock Quote
Data Provided by Refinitiv. Minimum 15 minutes delayed.
